Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thahir Farzan
Observed name:
T. Farzan
Observed institutions:
Mayo Clinic,
Bristol-Myers Squibb (United States)
OpenAlex ID:
A5008282923
Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth
2013
·
Marc A. Becker
, Thahir Farzan
, et al.
·
Molecular Cancer Therapeutics
·
7
Data from Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth
2023
·
Marc A. Becker
, Thahir Farzan
, et al.
Supplementary Figure 1 from Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth
2023
·
Marc A. Becker
, Thahir Farzan
, et al.
Supplementary Figure 1 from Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth
2023
·
Marc A. Becker
, Thahir Farzan
, et al.
PDF
Data from Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth
2023
·
Marc A. Becker
, Thahir Farzan
, et al.
Combined erbB/VEGFR blockade has improved anticancer activity over single-pathway inhibition in ovarian cancer in vivo
2011
·
T. Farzan
, S. Harrington
, et al.
·
Gynecologic Oncology
Show more works
View as search
Works count:
6
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type